About
A University of Iowa spin-off, started by the inventors.
The company
ZwiCoat Materials Innovations, LLC (ZCMI) makes ZwiGuard™, a zwitterionic hydrogel coating for medical devices.
The company is a University of Iowa spin-off. It was co-founded by the inventors of the coating.
An NIH SBIR Phase I award funded coated prototypes and feasibility work. An NIH SBIR Phase II award funds the cochlear implant program.
The company is based in Solon, Iowa, and is 100 percent founder owned.
Collaborators University of Iowa Departments of Otolaryngology and of Chemical and Biochemical Engineering; Brigham Young University (Guymon lab).
Leadership

Kameron R. Hansen, PhD
President and Chief Technology Officer
Bio
Dr. Kameron Hansen is the President and Chief Technology Officer of ZwiCoat and a research scientist trained in physics and materials chemistry. He earned a B.S. degree in physics from Brigham Young University, an M.S. degree in chemical physics from Columbia University, and a Ph.D. in physical chemistry from the University of Utah. His research on charge-transport in thin materials resulted in over 30 peer-reviewed publications, the Cheves T. Walling Graduate Research Award, and the prestigious Graduate Research Fellowship Program (GRFP). His proposal for applying zwitterionic coatings to medical devices was awarded by the NIH, resulting in SBIR funding to develop and commercialize zwitterionic coatings.

Marlan R. Hansen, MD
Chief Medical Officer and Co-founder
Bio
Dr. Marlan Hansen is a co-founder of ZwiCoat and a co-inventor of the company’s zwitterionic coating technology. In 2015, he co-founded iotaMotion, a company dedicated to developing advanced robotic-assisted systems for cochlear implant surgery, which is now expanding into international markets. As an expert clinician-scientist trained in neurotology and skull base surgery, as well as cell and molecular neurobiology, Dr. Hansen holds the position of Brian F. McCabe Distinguished Chair and DEO of Otolaryngology at the University of Iowa, where he is also a Professor of Neurosurgery and Molecular Physiology & Biophysics. His clinical practice focuses on cochlear implants and intricate surgeries of the inner ear and skull base, where he combines his extensive surgical expertise with a commitment to advancing medical technology for improved patient outcomes. His work has resulted in over 100 peer-reviewed publications and multiple patents.

C. Allan Guymon, PhD
Chief Scientific Officer and Co-founder
Bio
Dr. C. Allan Guymon is a co-founder of ZwiCoat and a co-inventor of the company's zwitterionic coating technology. With over thirty years of experience as a leader in photopolymerization, Dr. Guymon has made significant contributions to the field of chemical engineering, particularly in the areas of photopolymerization kinetics, polymer nanostructure formation, and the development of advanced materials for biomedical applications. Dr. Guymon was the Chair of the Chemical and Biochemical Engineering Department at the University of Iowa, where he led and shaped the department's academic and research initiatives, and currently serves as a professor of chemical engineering at Brigham Young University. His distinguished career includes numerous awards, such as the Presidential Early Career Award for Scientists and Engineering (PECASE) and the National Science Foundation CAREER Award. His work has resulted in over 80 peer-reviewed publications and multiple patents.

Leland G. Hansen, JD
Executive Chairman and Co-founder
Bio
Leland Hansen is a co-founder of ZwiCoat and an intellectual property attorney with a diverse practice that encompasses a wide range of technologies, including medical devices, angioplasty catheters, stents, and surgical equipment. He has served as lead counsel in numerous high-stakes cases before federal district courts, the International Trade Commission, and the Federal Circuit Court of Appeals. Leland's expertise extends to contested proceedings at the United States Patent and Trademark Office, where he has navigated complex reexaminations and inter partes reviews. Additionally, he has played a pivotal role in alternative dispute resolution proceedings such as mediation and binding arbitration on both domestic and international fronts. Beyond litigation, Leland provides strategic counsel on contract negotiation and due diligence for mergers and acquisitions, advising clients on intellectual property portfolio valuation and development strategies that drive innovation.